ASMB vs DOW · rev $21.6M vs P/E 74, rev $39.97B
Assembly Biosciences Inc (ASMB) versus Dow Inc (DOW) — a side-by-side from cached financials, not a winner call.
Assembly Biosciences Inc (ASMB) is a biotechnology company listed on US.
Dow Inc (DOW) is a chemicals company listed on US.
Latest reported ASMB revenue for 2026-06-30 was $21.6M. Net income was -$12.9M. ASMB currently screens at market cap $143.0M.
Latest reported DOW revenue for 2025-12-31 was $39.97B. Net income was -$2.44B. Revenue was down 7.0% from 2024-12-31 to 2025-12-31. DOW currently screens at market cap $20.89B and trailing P/E 73.9.
ASMB currently screens at market cap $143.0M. DOW currently screens at market cap $20.89B and trailing P/E 73.9.
Not investment advice. Open the ASMB and DOW stock pages for the full models.
Not investment advice.